Atricure Stock Cash Per Share
ATRC Stock | USD 20.89 1.33 5.99% |
AtriCure fundamentals help investors to digest information that contributes to AtriCure's financial success or failures. It also enables traders to predict the movement of AtriCure Stock. The fundamental analysis module provides a way to measure AtriCure's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AtriCure stock.
Last Reported | Projected for Next Year | ||
Cash Per Share | 2.96 | 1.72 |
AtriCure | Cash Per Share |
AtriCure Company Cash Per Share Analysis
AtriCure's Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Current AtriCure Cash Per Share | 2.55 X |
Most of AtriCure's fundamental indicators, such as Cash Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AtriCure is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
AtriCure Cash Per Share Driver Correlations
Understanding the fundamental principles of building solid financial models for AtriCure is extremely important. It helps to project a fair market value of AtriCure Stock properly, considering its historical fundamentals such as Cash Per Share. Since AtriCure's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of AtriCure's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of AtriCure's interrelated accounts and indicators.
Click cells to compare fundamentals
AtriCure Cash Per Share Historical Pattern
Today, most investors in AtriCure Stock are looking for potential investment opportunities by analyzing not only static indicators but also various AtriCure's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's cash per share growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of AtriCure cash per share as a starting point in their analysis.
AtriCure Cash Per Share |
Timeline |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Competition |
AtriCure Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, AtriCure has a Cash Per Share of 2.55 times. This is 41.38% lower than that of the Health Care Equipment & Supplies sector and 26.72% lower than that of the Health Care industry. The cash per share for all United States stocks is 49.1% higher than that of the company.
AtriCure Cash Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AtriCure's direct or indirect competition against its Cash Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AtriCure could also be used in its relative valuation, which is a method of valuing AtriCure by comparing valuation metrics of similar companies.AtriCure is currently under evaluation in cash per share category among related companies.
AtriCure Fundamentals
Return On Equity | -0.0817 | ||||
Return On Asset | -0.0386 | ||||
Profit Margin | (0.09) % | ||||
Operating Margin | (0.10) % | ||||
Current Valuation | 1.13 B | ||||
Shares Outstanding | 48.37 M | ||||
Shares Owned By Insiders | 3.07 % | ||||
Shares Owned By Institutions | 96.93 % | ||||
Number Of Shares Shorted | 3.2 M | ||||
Price To Earning | 33.47 X | ||||
Price To Book | 2.50 X | ||||
Price To Sales | 2.92 X | ||||
Revenue | 399.25 M | ||||
Gross Profit | 245.94 M | ||||
EBITDA | (16.28 M) | ||||
Net Income | (30.44 M) | ||||
Cash And Equivalents | 118.45 M | ||||
Cash Per Share | 2.55 X | ||||
Total Debt | 74.49 M | ||||
Debt To Equity | 0.16 % | ||||
Current Ratio | 3.66 X | ||||
Book Value Per Share | 9.77 X | ||||
Cash Flow From Operations | 4.42 M | ||||
Short Ratio | 4.21 X | ||||
Earnings Per Share | (0.66) X | ||||
Price To Earnings To Growth | (1.18) X | ||||
Target Price | 53.13 | ||||
Number Of Employees | 1.2 K | ||||
Beta | 1.37 | ||||
Market Capitalization | 1.07 B | ||||
Total Asset | 613.93 M | ||||
Retained Earnings | (357.06 M) | ||||
Working Capital | 191.68 M | ||||
Current Asset | 74.75 M | ||||
Current Liabilities | 31.59 M | ||||
Net Asset | 613.93 M |
About AtriCure Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AtriCure's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AtriCure using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AtriCure based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with AtriCure
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AtriCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will appreciate offsetting losses from the drop in the long position's value.Moving together with AtriCure Stock
0.75 | DH | Definitive Healthcare | PairCorr |
0.81 | LH | Laboratory | PairCorr |
Moving against AtriCure Stock
0.87 | EUDA | EUDA Health Holdings | PairCorr |
0.56 | CI | Cigna Corp | PairCorr |
0.52 | ESTA | Establishment Labs Earnings Call This Week | PairCorr |
0.49 | WORX | Scworx Corp | PairCorr |
0.47 | DXCM | DexCom Inc | PairCorr |
The ability to find closely correlated positions to AtriCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AtriCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AtriCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AtriCure to buy it.
The correlation of AtriCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AtriCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AtriCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AtriCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out AtriCure Piotroski F Score and AtriCure Altman Z Score analysis. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.66) | Revenue Per Share 8.923 | Quarterly Revenue Growth 0.164 | Return On Assets (0.04) | Return On Equity (0.08) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.